The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography.

OBJECTIVE To investigate the association of relative tumor echogenicity and hepatic steatosis in patients undergoing resection of colorectal liver metastases (CRLM). DESIGN Prospective study. SETTING The Johns Hopkins Hospital. PATIENTS A total of 126 patients undergoing liver surgery for CRLM from January 1, 1998, through December 31, 2008, in whom 191 lesions had complete intraoperative ultrasonography images for review and adequate linked pathological data available. MAIN OUTCOME MEASURES The intraoperative ultrasonography images were reviewed and scored for echogenicity (hypoechoic, isoechoic, or hyperechoic). In addition, a histopathologic review of the nontumorous liver tissue was performed, and the extent of steatosis was scored and correlated with tumor echogenicity. RESULTS Of the patients undergoing surgery, 49 (38.8%) were found to have mild to severe steatosis. Of the 191 total CRLM visualized by intraoperative ultrasonography, 91 (47.6%) were found to be hypoechoic, 65 (34.0%) were isoechoic, and 35 (18.3%) were hyperechoic. In patients with steatosis, lesions were significantly more likely to be hypoechoic when compared with patients without steatosis (odds ratio, 4.17; 95% confidence interval, 1.87-8.47; P = .001). Echogenicity was independent of the cause of steatosis or response to chemotherapy. CONCLUSIONS The echogenicity of CRLM was significantly affected by the presence of liver steatosis, with decreased echogenicity and increased conspicuity of lesions despite overall poorer image quality. These findings might reinforce the usefulness of intraoperative ultrasonography in identifying additional CRLM in patients undergoing surgical therapy, even in those with fatty liver tissue.

[1]  M. Choti,et al.  Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases. , 2008, Archives of surgery.

[2]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[3]  B. Sigel,et al.  Operative ultrasonography during hepatobiliary and pancreatic surgery , 1993, World Journal of Surgery.

[4]  Ying Lu,et al.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. , 2002, Radiology.

[5]  M. Choti,et al.  Echogenic Appearance of Colorectal Liver Metastases on Intraoperative Ultrasonography is Associated with Survival After Hepatic Resection , 2007, Journal of Gastrointestinal Surgery.

[6]  B. Nordlinger,et al.  Impact of Chemotherapy on the Accuracy of Computed Tomography Scan for the Evaluation of Colorectal Liver Metastases , 2009, Annals of Surgical Oncology.

[7]  A. Joseph,et al.  Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. , 1991, Clinical radiology.

[8]  E. Vasile,et al.  Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases , 2009, Annals of surgery.

[9]  M. Jacobs,et al.  The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. , 2003, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[10]  M. Fried,et al.  Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG‐PET‐CT , 2008, Journal of clinical ultrasound : JCU.

[11]  M. Thomas,et al.  The routine use of intra‐operative ultrasound in patients with colorectal cancer improves the detection of hepatic metastases , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[12]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[13]  Yuichi Harano,et al.  The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation , 2007, The American Journal of Gastroenterology.

[14]  O. Catalano,et al.  Real-time harmonic contrast material-specific US of focal liver lesions. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  P. Robinson.  The effects of cancer chemotherapy on liver imaging , 2009, European Radiology.

[16]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[17]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[18]  B. Siegel,et al.  Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. , 2002, AJR. American journal of roentgenology.

[19]  A. Napoli,et al.  Intra‐operative ultrasound for detection of liver metastases from colorectal cancer , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[20]  Catherine Julié,et al.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Reznek,et al.  Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. , 1998, British Journal of Cancer.

[22]  T. Gruenberger,et al.  Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. , 2008, Surgery.

[23]  K. Lindor,et al.  Role of radiologic modalities in the management of non-alcoholic steatohepatitis. , 2007, Clinics in liver disease.

[24]  T. Pawlik,et al.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  C. McArdle,et al.  Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. , 1995, Radiology.

[26]  M. F. Michael A. Choti MD.  Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned? , 2009, Annals of Surgical Oncology.

[27]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[28]  M. Choti,et al.  Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome , 2007, Journal of Gastrointestinal Surgery.